Drug testing lab Cetero Research recently offered assurances about the validity of its research and analysis following an announcement by the United States Food and Drug Administration regarding the deliberate misreporting of dates by chemists seeking to falsify their employee attendance records.

Six chemists at the company's Houston, Texas, bioanalytical laboratory were found to have misreported their hours to fraudulently claim overtime pay. In the process, they mislabeled dates of sample extractions prior to analysis in an attempt to provide false evidence that they had worked on the weekend.

An internal investigation by Cetero determined that the recording inaccuracies did not affect the validity of its findings. However, the FDA is currently in the process of sending letters to pharmaceutical companies advising them to reevaluate any results used to support applications for new drugs as a precautionary measure.

Cetero now faces FDA claims of misconduct and violation of federal regulations, alleging that its internal investigation was insufficient, its drug samples were manipulated and its documentation was falsified.

---

All data and information provided on this news blog is for informational purposes only. Infinisource makes no representations as to accuracy, completeness, suitability, or validity of any information on this site and will not be liable for any errors, omissions, or delays in this information or any losses, injuries, or damages arising from its display or use. All information is provided on an as-is basis. Information regarding employment suits and other legal action is not updated after publication, and may not be current.